Rafarma Pharmaceuticals, Inc. RAFA
Rating
Rating Factors
Company Overview
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) is a pharmaceutical-focused company that has historically been associated with the development, manufacturing, and commercialization of pharmaceutical products, with an emphasis on generic medicines and healthcare-related investments. Public disclosures indicate that the company has pursued opportunities tied to pharmaceutical production infrastructure and healthcare distribution, though the scope of active operations has varied over time based on available filings and market disclosures. Information regarding current large-scale commercial operations is limited in recent publicly accessible reporting.
The company’s historical positioning has been linked to pharmaceutical manufacturing assets and healthcare market participation in the Russian and broader Eurasian region. Available public records suggest that the company evolved through a combination of operating activities and investment-oriented corporate structuring tied to pharmaceutical production capabilities. Data regarding current revenue concentration, active product portfolios, and commercial scale is inconclusive based on available public sources.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $0.00
- Current
- $0.03
- High
- $0.09
Dividends and Shares
Corporate Info
Suite 1
Sandy, UT 84070